Comprehensive One Health Framework Study Notes

Avian Die-off and Encephalitis Outbreak in New York (1999)

  • Avian mortality events: Between May and November 19991999, over 15,00015,000 dead birds, predominantly crows, were reported falling dead from the sky across New York City and surrounding regional areas.
  • Bronx Zoo deaths: Unprecedented deaths occurred among exotic birds at the Bronx Zoo, including a cormorant, several flamingos, and a bald eagle.
  • Clinical and pathological observations: Doctor Tracy McNamara, Head Veterinary Pathologist at the Bronx Zoo, observed that dying birds exhibited severe neurological symptoms prior to death. Subsequent necroscopies revealed severe bleeding (hemorrhaging) within the birds' brains and major organs, pointing to an infectious cause.
  • Inter-agency coordination failures:
    • Avian tissue samples sent to the New York State Department of Environmental Conservation could not be analyzed due to lack of specialized equipment.
    • The Centers for Disease Control (CDC), the premier federal public health agency in the United States, declined to test the bird samples, explicitly stating they were busy dealing with human illnesses and did not deal with birds.
  • Human illness emergence: In late August 19991999, an infectious disease specialist at a hospital in Queens, New York City, alerted the New York City Department of Health after encountering 22 patients presenting with encephalitis (brain inflammation) within a short timeframe.
  • Patient epidemiology and clinical features:
    • Rapid surveillance across local hospitals identified 66 additional cases of encephalitis in previously healthy individuals aged 58 to 87 years58\,\text{to}\,87\,\text{years}.
    • Patients presented with fever accompanied by alterations in mental status.
    • Severe muscle weakness affected 55 of the 66 patients (83.3%83.3\%), with 44 requiring mechanical ventilator support.
    • Cerebrospinal fluid analysis indicated a viral etiology.
  • Epidemiological field investigation: CDC investigators interviewed patient families but found no common indoor exposures. However, all patients engaged in outdoor evening activities such as gardening around their homes. Field evaluations confirmed mosquito breeding sites and larvae in patients' yards and neighborhoods, pointing to a mosquito-borne virus.
  • Initial diagnostic finding: Diagnostic testing of blood samples from human patients yielded positive antibody tests for St. Louis encephalitis virus, a mosquito-borne virus transmitted from infected birds to humans that was previously known in the area. Disease onset peaked towards the end of August 19991999

Viral Identification and Serological Cross-Reactivity

  • Initial public health intervention: Following the positive St. Louis encephalitis antibody tests, New York City initiated targeted pesticide spraying against vector mosquitoes, distributed mosquito repellent, and issued public health warnings to restrict outdoor activity during peak mosquito hours, which successfully lowered human incidence rates.
  • Discrepancies identified by Doctor McNamara:
    • St. Louis encephalitis virus can cause human disease via targeted mosquito species, but it rarely kills birds.
    • Viral particle analysis conducted by the United States Department of Agriculture (USDA) National Veterinary Services Lab showed that the viral cause of disease in the dead zoo birds was physically too small to be St. Louis encephalitis virus.
  • Discovery of West Nile virus: Doctor McNamara utilized personal contacts at the US Army Medical Research Institute (a biological defense facility with extensive viral testing resources). Screening tissue samples against a global panel of pathogens identified the cause as West Nile virus, a closely related virus never before detected in the Western Hemisphere that can kill humans.
  • Diagnostic mechanism of cross-reactivity:
    • Both St. Louis encephalitis virus and West Nile virus are closely related members of the Japanese encephalitis virus complex within the Flavivirus family.
    • Surface antigens on St. Louis encephalitis virus and West Nile virus are structurally similar, causing blood-based diagnostic serology testing to demonstrate cross-reactivity and rendering standard serological tests incapable of distinguishing between the two viruses.
  • Vector and host dynamics:
    • All viruses in the Japanese encephalitis virus complex utilize Kulix mosquitoes as vectors.
    • Both West Nile virus and St. Louis encephalitis virus exist in a natural transmission cycle between wild birds and Kulix mosquitoes.
    • Humans function as dead-end hosts, meaning the virus cannot be transmitted from an infected human to another host.

The One Health Framework and Emerging Infectious Diseases

  • Geographical and epidemiological status: St. Louis encephalitis virus has long been endemic to the Southern United States. West Nile virus was first identified in Africa; following its introduction in 19991999, its incidence rose continuously, rendering it endemic to North America. West Nile virus has caused over 50,000 cases50,000\,\text{cases} and 2,400 deaths2,400\,\text{deaths} in North America.
  • Consequences of siloed health systems: The massive avian mortality was an unheeded early warning sign. Siloed surveillance systems failed to connect avian and human deaths occurring simultaneously from the same pathogen over several weeks. Bird tissue samples were essential to establishing the correct human diagnosis.
  • Definition of One Health: Defined by the World Health Organization (WHO) as a collaborative, multi-sectoral, and transdisciplinary approach to achieving optimal health outcomes that recognizes the interconnection between people, animals, and plants and their shared environment. It seeks to sustainably balance and optimize the health of humans, animals, plants, and ecosystems across all levels along the continuum.
  • Quantitative evidence on zoonotic diseases:
    • Over 60%60\% of emerging infectious diseases in humans originate in animals (zoonotic diseases).
    • Systematic tracking of emerging infectious disease events between 1940 and 20001940\,\text{and}\,2000 demonstrates that zoonoses account for the overwhelming majority of disease emergence events, with the rate of emergence increasing over time.
    • Among 3030 new human pathogens identified over the past 30 years30\,\text{years}, 75%75\% are of animal origin (e.g., HIV originating from chimpanzees, and influenza strains emerging from birds and swine).
    • Among emerging viruses specifically, nearly 90%90\% are zoonotic, with roughly two-thirds (≈66.7%\approx 66.7\%) resulting from spillover from wildlife rather than pets or livestock.
  • Environmental drivers of pathogen spillover:
    • Deforestation, agricultural intensification, and urbanization increase human contact with wildlife interfaces.
    • Global forest loss since 19901990 totals 420,000,000 hectares420,000,000\,\text{hectares}, an area larger than the European Union.
    • Human consumption of wildlife meat sourced from wet markets facilitates pathogen transmission from animals to humans.
  • One Health surveillance tools in practice:
    • Community wastewater surveillance utilized to track SARS CoV-two spread during the COVID-nineteen pandemic.
    • Canadian Food Inspection Agency policies mandating federal reporting of suspected cases of key infectious diseases such as Rift Valley Fever.
    • Rapid point-of-care diagnostic tests used to cheaply monitor disease presence during outbreaks like COVID-nineteen.

Combating Antimicrobial Resistance

  • Multidisciplinary nature of Antimicrobial Resistance (AMR): Referred to as the quintessential One Health problem because resistant microbes cross environmental, agricultural, animal, and human domains.
  • Antifungal resistance impacts across domains:
    • Human clinical impact in the United States: Fungal diseases cause approximately 75,000 hospitalizations75,000\,\text{hospitalizations} and 9,000,000 outpatient visits9,000,000\,\text{outpatient visits} annually. Aspergillus pemigatus is a ubiquitous fungus that causes fatal systemic disease in immunocompromised patients.
    • Animal impact: Chytrid fungus has decimated global amphibian populations.
    • Agricultural impact: Fusarial milt threatens global banana production.
  • Treatment challenge: Human and fungal cells are both periodic, making it exceptionally difficult to design targeted antifungal drugs without host toxicity.
  • Environmental selection pressure: Agricultural antifungal pesticides select for drug-resistant fungi in soil and plants. Environmental isolates of Aspergillus pemigatus have demonstrated resistance to clinical antifungal drugs used in human medicine, leading to treatment failures.

The DRUM Protocol and Resistance Drivers in Sub-Saharan Africa

  • Program overview: The DRUM Protocol stands for Drivers of Resistance in Uganda and Malawi. It addresses high morbidity and mortality from severe bacterial infections complicated by antimicrobial resistance in Sub-Saharan Africa.
  • Molecular resistance mechanism: Focuses on Extended Spectrum Beta-Lactamases (ESBLs), a prevalent drug-resistance mechanism easily transferred between bacterial species via horizontal gene transfer.
  • Local situational drivers of AMR:
    • Inadequate Water, Sanitation, and Hygiene (WASH) infrastructure.
    • Insufficient health system infrastructure for accurate bacterial diagnosis and treatment.
    • Uncontrolled, widespread availability of antimicrobial medications over the counter.
  • Research methodology of the DRUM Consortium:
    • Repeated sampling of environmental sites and residential households in urban and rural locations across Uganda and Malawi.
    • Whole-genome sequencing of isolated bacterial samples to detect ESBL genes.
    • Comprehensive surveys assessing community WASH practices, health-seeking behaviors, and animal care methods.
    • Direct observational studies tracking household WASH practices.
    • Integration of empirical data into predictive mathematical models describing ESBL transmission to design targeted public health interventions.
  • Key research findings: Human carriage of ESBL-producing bacteria was significantly associated with the wet season and close physical interaction with domestic animals. Without substantial improvements in environmental health, bacterial transmission will persist.
  • Required stakeholders: Interdisciplinary integration requires medical doctors, nurses, epidemiologists, pharmacists, wildlife researchers, medical researchers, veterinarians, ecologists, farmers, community members, community leaders, politicians, and social scientists such as economists.

Implementation Challenges and Structural Siloes

  • Economic considerations: While comprehensive One Health protocols require high initial funding, preventing a global pandemic is estimated to cost less than 2%2\% of the financial cost incurred when responding to an active pandemic.
  • Structural and institutional barriers:
    • Government agencies and research funding bodies operate in rigid disciplinary siloes, as demonstrated by the CDC initially refusing to evaluate avian samples during the 19991999 outbreak.
    • Targeted research grants frequently fail to fund environmental reservoir interventions unless a broad systems-level perspective is mandated.
    • Historical oversight and exclusion of Indigenous peoples and local communities from health policy planning.
    • Technical difficulty in executing cross-disciplinary data sharing across isolated research sectors.